Related Experiment Video
Updated: Sep 4, 2025
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
7.0K
Understanding clinical decision-making in mesothelioma care: a mixed methods study
Catherine Henshall1,2, Paul Dawson3, Najib Rahman4,5,6
1Oxford School for Nursing and Midwifery, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK chenshall@brookes.ac.uk.
BMJ Open Respiratory Research
|July 15, 2022
Summary
Improving mesothelioma care requires better multidisciplinary team meetings. Enhancing collaboration and knowledge sharing among clinicians is crucial for optimizing treatment decisions and patient outcomes in malignant pleural mesothelioma care.
Area of Science:
- Oncology
- Public Health
- Clinical Decision-Making
Background:
- Malignant pleural mesothelioma is a rare, incurable cancer with poor prognosis, often linked to asbestos exposure.
- Clinical decision-making in mesothelioma care shows significant variation due to fragmented knowledge sharing.
- Optimizing the mesothelioma care pathway is essential for improving patient outcomes.
Purpose of the Study:
- To explore factors influencing clinicians' decision-making in mesothelioma care.
- To identify barriers and facilitators in the mesothelioma care pathway.
- To provide recommendations for improving mesothelioma multidisciplinary team meetings.
Main Methods:
- A mixed-methods approach was employed, including documentary analysis of guidelines and policies.
- Secondary analysis of patient data (diagnosis, treatment, survival) was conducted.
- Qualitative interviews with clinicians involved in lung cancer/mesothelioma multidisciplinary teams were performed.
Main Results:
- Differences in treatment and care delivery were observed across healthcare trusts.
- Key themes identified include collaboration, communication, evidence base, clinician roles, and patient roles.
- Cross-cutting themes involved the mesothelioma nurse specialist and COVID-19 impact.
Conclusions:
- Mesothelioma multidisciplinary team meetings need structural review to ensure appropriate clinician expertise.
- Enhancing the evidence and knowledge base within multidisciplinary teams is vital.
- Promoting expert-led knowledge sharing can optimize mesothelioma patient care pathways.
Related Concept Videos
01:30Pleural Disorders: Types and Brief Description
289
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
289
01:21Cancer Survival Analysis
442
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
442
01:24Kaplan-Meier Approach
246
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
246
01:15Methods of Documentation VI: Case Management Model
622
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
622
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:30Ethical Dilemmas II
1.3K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
1.3K